Prestige Consumer Healthcare Inc
NYSE:PBH
Prestige Consumer Healthcare Inc
Other Assets
Prestige Consumer Healthcare Inc
Other Assets Peer Comparison
Competitive Other Assets Analysis
Latest Figures & CAGR of Competitors
Company | Other Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Prestige Consumer Healthcare Inc
NYSE:PBH
|
Other Assets
$527.9m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
11%
|
|
Johnson & Johnson
NYSE:JNJ
|
Other Assets
$36.6B
|
CAGR 3-Years
1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
5%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Other Assets
$21.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
27%
|
CAGR 10-Years
12%
|
|
Pfizer Inc
NYSE:PFE
|
Other Assets
$67.8B
|
CAGR 3-Years
11%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
Merck & Co Inc
NYSE:MRK
|
Other Assets
$21.2B
|
CAGR 3-Years
2%
|
CAGR 5-Years
3%
|
CAGR 10-Years
6%
|
|
Eli Lilly and Co
NYSE:LLY
|
Other Assets
$4.9B
|
CAGR 3-Years
8%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
See Also
What is Prestige Consumer Healthcare Inc's Other Assets?
Other Assets
527.9m
USD
Based on the financial report for Dec 31, 2023, Prestige Consumer Healthcare Inc's Other Assets amounts to 527.9m USD.
What is Prestige Consumer Healthcare Inc's Other Assets growth rate?
Other Assets CAGR 10Y
11%
Over the last year, the Other Assets growth was -8%. The average annual Other Assets growth rates for Prestige Consumer Healthcare Inc have been -3% over the past three years , -3% over the past five years , and 11% over the past ten years .